PlasmaTech Biopharmaceuticals to Present at the 2015 Marcum MicroCap Conference
May 27, 2015 08:03 ET
|
PlasmaTech Biopharmaceuticals
DALLAS, TX and NEW YORK, NY--(Marketwired - May 27, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and...
REMINDER: PlasmaTech Biopharmaceuticals First Quarter 2015 Conference Call Tomorrow
May 26, 2015 13:15 ET
|
PlasmaTech Biopharmaceuticals
NEW YORK, NY--(Marketwired - May 26, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based...
PlasmaTech Biopharmaceuticals Announces Orphan Drug and Rare Pediatric Disease Designations From FDA
May 20, 2015 08:03 ET
|
PlasmaTech Biopharmaceuticals
NEW YORK, NY--(Marketwired - May 20, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on gene therapy and plasma-based products for severe and life-...
PlasmaTech Biopharmaceuticals Closes Abeona Therapeutics Acquisition
May 18, 2015 08:03 ET
|
PlasmaTech Biopharmaceuticals
NEW YORK, NY--(Marketwired - May 18, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on gene therapy and cell therapy products for severe and life-...
PlasmaTech Biopharmaceuticals Files First Quarter 2015 Financial Results and Announces Conference Call to Provide Business Update
May 15, 2015 08:03 ET
|
PlasmaTech Biopharmaceuticals
NEW YORK, NY--(Marketwired - May 15, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on gene therapy and cell therapy products for severe and life-...
PlasmaTech Biopharmaceuticals Announces Completion of Sanfilippo Syndrome (MPS IIIB) Toxicology Studies at American Society of Gene and Cell Therapy Annual Meeting
May 14, 2015 08:03 ET
|
PlasmaTech Biopharmaceuticals
NEW ORLEANS, LA--(Marketwired - May 14, 2015) - Preclinical Studies Support Strong Safety Profile and Investigational New Drug (Ind) Application Filing for Treating Sanfilippo Syndrome...
PlasmaTech Biopharmaceuticals Announces Appointment of Todd Wider, MD to Board of Directors
May 12, 2015 09:03 ET
|
PlasmaTech Biopharmaceuticals
DALLAS, TX and NEW YORK, NY--(Marketwired - May 12, 2015) - PlasmaTech Biopharmaceuticals, Inc. ("PlasmaTech" or the "Company") (NASDAQ: PTBI), a biopharmaceutical company focused on advancing cell...
PlasmaTech Biopharmaceuticals Closes $10 Million Financing
May 11, 2015 14:51 ET
|
PlasmaTech Biopharmaceuticals
DALLAS, TX and NEW YORK, NY--(Marketwired - May 11, 2015) - PlasmaTech Biopharmaceuticals, Inc. ("PlasmaTech" or the "Company"), (NASDAQ: PTBI), a biopharmaceutical company focused on advancing cell...
PlasmaTech Biopharmaceuticals' Announces $10 Million Private Placement
May 06, 2015 13:32 ET
|
PlasmaTech Biopharmaceuticals
DALLAS, TX and NEW YORK, NY--(Marketwired - May 06, 2015) - PlasmaTech Biopharmaceuticals, Inc. ("PlasmaTech" or the "Company"), (NASDAQ: PTBI), announced today that it has entered into a definitive...
PlasmaTech Biopharmaceuticals Announces Agreement to Acquire Abeona Therapeutics LLC
May 06, 2015 06:03 ET
|
PlasmaTech Biopharmaceuticals
DALLAS, TX and CLEVELAND, OH and NEW YORK, NY--(Marketwired - May 06, 2015) - Company is well positioned to execute on its strategy to become a leader in cell therapy and gene therapy for rare...